Skip to main content
Log in

Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke

  • ORIGINAL
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract.

The role of hyperhomocysteinemia as independent risk factor for stroke needs to be confirmed. The aims of our study were to assess (i) the association between risk of stroke and increasing values of plasma homocysteine and (ii) the interaction between mild hyperhomocysteinemia and conventional vascular risk factors. We studied 161 consecutive patients with first-ever ischemic stroke classified using TOAST criteria and 152 neurologically healthy controls. Homocysteine was measured using high performance liquid chromatography (HPLC). Homocysteinemia was elevated in all stroke subtypes: 13.0±2.5 µmol/l in patients with cardioembolic disease, 13.9±5.4 µmol/l in those with small vessel diseases, 15.5±6.8 µmol/l in cases of undetermined stroke, and 17.8±13.5 µmol/l in patients with large vessel disease. Mean homocysteinemia was 8.10 µmol/l (SD=2.5) in controls. The logistic regression analysis showed that important independent risk factors for ischemic stroke were hypertension (p<0.0001; OR= 3.205; 95% CI, 1.788–5.742), hyperhomocysteinemia (p<0.0001; OR=1.425; 95% CI, 1.300–1562) and hyperlipidemia (p=0.018; OR=2.243; 95% CI, 1.147–4.385). Hyperhomocyst(e)inemia is an independent risk factor for all stroke subtypes and should be routinely measured and treated in stroke patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. Parnetti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parnetti, L., Caso, V., Santucci, A. et al. Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke. Neurol Sci 25, 13–17 (2004). https://doi.org/10.1007/s10072-004-0219-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-004-0219-5

Key words

Navigation